Trends in analgesia-sedation of pediatric patients receiving I-131 MIBG in the pediatric intensive care unit: A report from the Pediatric Health Information System database.
Jordann DhuseThomas CashMichael S ElgesAdina AlazrakiRachael BeerAndrew JergelKelly C GoldsmithMatt HallPradip P KamatPublished in: Pediatric blood & cancer (2024)
Using PHIS data, we discovered considerable variability in the medications used for sedation in patients undergoing MIBG therapy. Although benzodiazepines and opioids were the most used agents, there was a trend toward decreasing use of benzodiazepines and opioids in these patients. Furthermore, there has been an increasing trend in the use of dexmedetomidine and ketamine.
Keyphrases
- health information
- pain management
- intensive care unit
- patients undergoing
- chronic pain
- end stage renal disease
- mechanical ventilation
- ejection fraction
- newly diagnosed
- social media
- chronic kidney disease
- healthcare
- peritoneal dialysis
- cardiac surgery
- young adults
- machine learning
- acute kidney injury
- big data
- mesenchymal stem cells
- acute respiratory distress syndrome
- deep learning
- extracorporeal membrane oxygenation